巨細胞性動脈炎 (特集 高齢者におけるリウマチ・膠原病のマネージメント)
Digital data available（科学技術振興機構）
Begin reading now
J-STAGE
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
J-STAGE
DigitalCiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Title
- Author/Editor
- 山田 秀裕伊東 宏
- Series Title
- Alternative Title
- Giant cell arteritis
- Periodical title
- 日本内科学会雑誌 = Journal of the Japanese Society of Internal Medicine
- No. or year of volume/issue
- 106(10):2017.10.10
- Volume
- 106
- Issue
- 10
- Pages
- 2136-2142
- Publication date of volume/issue (W3CDTF)
- 2017-10-10
- ISSN (Periodical Title)
- 0021-5384
- ISSN-L (Periodical Title)
- 0021-5384
- Publication (Periodical Title)
- 東京 : 日本内科学会
- Place of Publication (Country Code)
- JP
- Text Language Code
- jpn
- Subject Heading
- NDLC
- Target Audience
- 一般
- Holding library
- 国立国会図書館
- Call No.
- Z19-222
- Data Provider (Database)
- 国立国会図書館 : 国立国会図書館雑誌記事索引
- Bibliographic ID (NDL)
- 028610737
- Bibliographic Record Category (NDL)
- 632
- Summary, etc.
- <p>巨細胞性動脈炎（giant cell arteritis：GCA）は，合併症の多い高齢者に好発する疾患である．従って，巨細胞性動脈炎に対する治療を標準的ステロイド大量療法で行うと，多くの合併症を増悪・併発させ，QOL（quality of life）や生命予後の著しい低下を招いてしまう．感染症を含む合併症予防管理等の継続的マネージメントが重要である．最新の分子標的薬等の開発とその臨床応用は，GCAの寛解導入・寛解維持療法におけるステロイド依存からの脱却を可能にするかもしれない．</p>
- DOI
- 10.2169/naika.106.2136
- Access Restrictions
- インターネット公開
- Data Provider (Database)
- 科学技術振興機構 : J-STAGE
- Summary, etc.
- <p>巨細胞性動脈炎（giant cell arteritis：GCA）は，合併症の多い高齢者に好発する疾患である．従って，巨細胞性動脈炎に対する治療を標準的ステロイド大量療法で行うと，多くの合併症を増悪・併発させ，QOL（quality of life）や生命予後の著しい低下を招いてしまう．感染症を含む合併症予防管理等の継続的マネージメントが重要である．最新の分子標的薬等の開発とその臨床応用は，GCAの寛解導入・寛解維持療法におけるステロイド依存からの脱却を可能にするかもしれない．</p>
- DOI
- 10.2169/naika.106.2136
- Related Material (URI)
- References
- Trial of Tocilizumab in Giant-Cell ArteritisAdjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysisRisk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell ArteritisLarge-vessel giant cell arteritis: a cohort studyTocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialLarge vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiographyGiant Cell Arteritis with or without Aortitis at Diagnosis. A Retrospective Study of 22 Patients with Longterm FollowupA Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell ArteritisClinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: The first government‐supported nationwide surveyRisk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patientsThe relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UKLarge-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosisTHE THERAPEUTIC IMPACT OF TEMPORAL ARTERY BIOPSYAdalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
- Data Provider (Database)
- 国立情報学研究所 : CiNii Research
- Original Data Provider (Database)
- Japan Link Center雑誌記事索引データベースCrossrefCiNii Articles
- Bibliographic ID (NDL)
- 028610737
- NAID
- 130007496797